Clinical Study Data Request Registered Users, Please Login

Find by:

Study ID:
Medicine:
Phase:

A Phase II, single-arm, open-label study, of Trastuzumab-MCC-DM1 adminstered intravenously to patients with HER2-positive metastatic breast cancer
trastuzumab emtansine
TDM4374g
NCT00679211
metastatic breast cancer
Phase 2
 
January 2014

Powered by ideaPoint, Inc.